Gilead Sciences, INC.

American biotechnology company that researches, develops and commercializes drugs.

Based in CA

🤖

AI Overview

With $1.4M in lobbying spend across 24 quarterly filings, Gilead Sciences, INC. is a significant lobbying presence.

$1.4M
Total Lobbying Spend
24
Quarterly Filings
1
Lobbying Firms Used
1
Individual Lobbyists

Spending by Year

YearLobbying Spend
2019$180K
2020$240K
2021$180K
2022$240K
2023$240K
2024$180K
2025$180K

Lobbying Firms

W STRATEGIES, LLC

What They Lobby For

  • 6 protected classes. Medicare Part D.
  • Education about CMS rule changing protections for beneficiaries in Medicare Part D six protected classes. Regulatory and legislative proposals in the Administrations Drug Pricing Blueprint.
  • Education around access to HIV therapies.
  • Regulator and legislative proposals in the Administration's Drug Pricing Blueprint. H.R.3: Lower Drug Costs Now Act of 2019. S.2543: Prescription Drug Pricing Reduction Act of 2019.
  • Regulatory and legislative proposals in the Administration's Drug Pricing Blueprint. H.R.3: Lower Drug Costs Now Act of 2019. H.R.19: Lower Costs, More Cures Act of 2019. S.2543: Prescription Drug Pricing Reduction Act of 2019.
  • Issues related to potential therapies for COVID-19.
  • Education around and issues related to potential therapies for COVID-19.
  • CMS proposed rule on Medicaid Drug Rebate program.
  • H.R.3: Elijah E. Cummings Lower Drug Costs Now Act. H.R.19: Lower Costs, More Cures Act of 2021.
  • Education around therapies for COVID-19. Education around copay accumulators.

Related Investigations

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.